BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17237962)

  • 1. 123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients.
    Keyaerts M; Lahoutte T; Neyns B; Caveliers V; Vanhove C; Everaert H; Kersemans K; Franken PR; Mertens J; Bossuyt A
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):994-1002. PubMed ID: 17237962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic tumour imaging agents for glioma evaluation: 99mTc-tetrofosmin.
    Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2143-4. PubMed ID: 17891392
    [No Abstract]   [Full Text] [Related]  

  • 3. Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport.
    Tolvanen T; Någren K; Yu M; Sutinen E; Havu-Aurén K; Jyrkkiö S; Asola M; Kotoneva E; Nuutila P; Minn H
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1178-84. PubMed ID: 16721566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.
    Kauppinen TA; Bergström KA; Heikman P; Hiltunen J; Ahonen AK
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):132-6. PubMed ID: 12483421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects.
    Ueda M; Iida Y; Mukai T; Mamede M; Ishizu K; Ogawa M; Magata Y; Konishi J; Saji H
    Ann Nucl Med; 2004 Jun; 18(4):337-44. PubMed ID: 15359928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine.
    Bauwens M; Keyaerts M; Lahoutte T; Kersemans K; Caveliers V; Bossuyt A; Mertens J
    Nucl Med Commun; 2007 Oct; 28(10):823-8. PubMed ID: 17728613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-O-methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging.
    Beuthien-Baumann B; Bredow J; Burchert W; Füchtner F; Bergmann R; Alheit HD; Reiss G; Hliscs R; Steinmeier R; Franke WG; Johannsen B; Kotzerke J
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1004-8. PubMed ID: 12768333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
    Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
    Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
    Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
    Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
    Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
    Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
    J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging glioma extent with 131I-TM-601.
    Hockaday DC; Shen S; Fiveash J; Raubitschek A; Colcher D; Liu A; Alvarez V; Mamelak AN
    J Nucl Med; 2005 Apr; 46(4):580-6. PubMed ID: 15809479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas.
    Torres LA; Coca MA; Batista JF; Casaco A; Lopez G; García I; Perera A; Peña Y; Hernández A; Sanchez Y; Romero S; Leyva R; Prats A; Fernandez R
    Nucl Med Commun; 2008 Jan; 29(1):66-75. PubMed ID: 18049099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
    Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
    Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers.
    Ribeiro MJ; Ricard M; Bourgeois S; Lièvre MA; Bottlaender M; Gervais P; Dollé F; Syrota A
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):952-8. PubMed ID: 15841376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging.
    Rijks LJ; Busemann Sokole E; Stabin MG; de Bruin K; Janssen AG; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):40-7. PubMed ID: 9396873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
    Kersemans V; Cornelissen B; Kersemans K; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
    Nucl Med Biol; 2006 Jan; 33(1):111-7. PubMed ID: 16459266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and dosimetry of [123I]iodo-PK 11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor.
    Versijpt J; Dumont F; Thierens H; Jansen H; De Vos F; Slegers G; Santens P; Dierckx RA; Korf J
    Eur J Nucl Med; 2000 Sep; 27(9):1326-33. PubMed ID: 11007514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.